# Moexipril for Primary Biliary Cirrhosis

> **NCT00588302** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Primary Biliary Cirrhosis

## Interventions

- **DRUG:** Moexipril

## Key facts

- **NCT ID:** NCT00588302
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00588302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00588302, "Moexipril for Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00588302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*